Harden v. Danek Medical, Inc.

IN THE COURT OF APPEALS OF TENNESSEE AT KNOXVILLE FILED August 31, 1998 DON HARDEN, Cecil Crowson, Jr. ) C/A NO. 03A01-9801-CV-00020 Appellate C ourt Clerk ) Plaintiff-A ppellant, ) KNOX CIRCU IT ) v. ) HON. WHEELER ROSENBALM, ) JUDGE DAN EK M EDIC AL, IN C., ) ) AFFIRMED AND Defendant-Appellee. ) REMANDED CLINT J. WOOD FIN, RALPH BRO WN & A SSOCIATES, Knoxville, for Plaintiff- Appellan t. ROBERT R. CAMPBE LL, HODGES, DOUGHTY & CARSON, and STEPHEN S. PHILLIPS AND JAMES M. BECK, PEPPER HAMILTON, LLP, Philadelphia, PA, for Defendant-Appellee. O P I N IO N Franks, J. In this action for allegedly manufacturing a defective product which harmed plaintiff, the Trial Judge granted defendant summary judgment, and plaintiff has appealed. The principal issue on appeal stated in plaintiff’s brief is: Did the Trial Court commit reversible error by holding that no genuine issues of material fact existed in the record on August 19, 1997, and granting summary judgment to the defendant on that basis. Appellant in his brief argu es that the Trial Judge com mitted several errors which were not specified as issues in the statement of issues. The issue as stated is simply not reviewable. We said in Leeson v. Chernau, 737 S.W.2d 634 (Tenn. App. 1987) p.637: T.R.A.P. does not contemplate that an appellant may submit one blanket issue as to the correctness of the judg ment and thereby open the door to argument upon various issues which might affect the correctness of the judgmen t. Since the appellee eff ectively cured this defect by filing a “counter- statement of the issues presented”, we will consider the issues presented. This case arises from an operation that was performed by Dr. Glenn Jeffries in 1992 on the plaintiff who had been suffering back pain. Dr. Jeffries determined that plaintiff would benefit from back surgery stabilized by spinal instrumentation. In March of 1992, Dr. Jeffries performed the surgery and implanted a construct built from components made by Defendant Danek Medical , Inc. (“Danek”). In the operative procedure, Dr. Jeffries used bone screws to attach the construct through the pedicles of plaintiff’s vertebrae.1 Plaintiff’s condition improved after surgery, but in July of 1993 his pain returned. On August 8, 1995, plaintiff underwent surgery to have the hardware removed from his back. This action then followed in October 1995, wherein plaintiff alleged injuries from the implantation of a Danek device that was defective and/or unreasonably dangerous. In June 1996, Danek filed a Motion for Judgment on the Pleadings, arguing that the complaint failed to state a cause of action. Plaintiff moved to amend his complaint on July 17, 1996. On July 30, 1996, the Trial Court granted Danek’s motion and dismissed the amended complaint. However, on August 8, 1996, plaintiff mo ved to file a s econd am ended co mplaint an d for recon sideration of the July 30 order. The Trial Court allowed the second amended complaint, but denied reconsideration of its dismissal of the claims in the first amended complaint. On June 4, 1997, Danek moved for summary judgment on the allegations in the second amended compliant, and as a part of that motion, Danek included Dr. Jeffries’ 1 Each vertebra has left and right pedicles which face out and are more readily accessible to a surgeon than other parts of the vertebra. 2 deposition. On June 30, 1997 plaintiff gave notice to depose Dr. Jeffries. On August 15, 1997, plaintiff filed a N otice of Deposition. O n August 19, 19 97, the Trial Court quashed the N otice and denied plaintiff’s M otion to Amend and granted D anek’s Motio n for S umm ary Judg ment. Plaintiff contends that the T rial Court erred in granting sum mary judgment on his fa ilure to warn claim. He a rgues that defendan t owed a duty to warn him that the safety of its system had been determined only for certain types of conditions and that implanting a pedicle screw system was a potentially dangerous proced ure that o nly expe rienced surgeo ns perf ormed . As the moving party for summary judgment, the defendant had the burden of dem onstratin g that no genuin e issue o f mater ial fact e xisted. Shadrick v. Coker, 963 S.W.2d 726 (Tenn. 1998). On appeal “we are required to view the evidence in the light mo st favorab le to the non -moving party, draw all re asonable inferen ces in h is favo r, and di scard a ll counte rvailing eviden ce.” Id. Summary judgmen t is only proper “[ i]f both the f acts and co nclusions to be draw n from the facts permit a reasonable person to reach only one conclusion . . .” Id. Summary judgment was proper on this issue because the treating physician was aware of the risks and limitations of the surgery he performed with the hardw are he in stalled. T he def endan t relied o n the de fense o f learne d interm ediary. Under th is doctrine, m anufactu rers of certain medical p roducts “m ay reasonably rely on intermediaries to transmit their warnings and instructions.” Pittma n v. Up john C o., 890 S.W.2d 425, 429 (Tenn. 1994). This defense is based upon the pivotal role that physician s play in the distribu tion of p rescriptio n prod ucts. Id. Physicians can be learned interme diaries o nly whe n they rec eive ad equate warnin gs. Id. Thus, manufa cturers are no t shielded fro m liability if they prov ide inadeq uate warn ings to physician s. Id. 3 In order to recover for fa ilure to warn under the lea rned intermediary doctrine, a plaintiff must show : (1) that the defendant failed to warn the physician of a risk associated with the use of the product not otherwise known to the physician; and (2) that the failure to warn the physician was both a cause in fact and proximate cause of the plaintiff’s injury. 63A Am.Jur.2d Products Liability §1200 (1984 ). Generally, “a m anufactu rer will be ab solved of liability for failure to warn for lack of causation where the consumer w as already aware of the da nger, because the failure to warn cannot be the proximate cause of the user’s injury if the user had actual knowledge of the hazards in question.” Id. at §1162. U nder this doctrine, ph ysicians are the “ consum ers” who must be w arned. Th us, it is generally held that the le arned interm ediary doctrine may shield a m anufactu rer from liab ility when the physician was independently aware of the risks involved. Id. at §116 2. See Odom v. G.D . Searle & Co., 979 F.2d 1001 (4th Cir. 1992) (applying South Carolina law); Stanback v. Parke, Davis & Co., 657 F.2d 642 (4th C ir. 1981)(ap plying Virginia law); Spych ala v. G .D. Sea rle & Co ., 705 F.Supp. 1024 (D.N.J. 1988) (applying New Jersey law); Ashman v. SK & F Lab Co., 702 F.Supp 1401 (N.D. Ill. 1988)(applying Illinois law); Zanzuri v. G.D. Searle & Co., 748 F.Supp. 1511 (S.D. Fla. 1990)(ap plying Florida la w); Andre v. Mecta Corp., 587 N.Y.S.2d 334, (NY. App. Div. 1992) appeal denied, 648 N .E.2d 7 91. In Dr. Jeffries’ affidavit submitted by defendant, he stated that he was fully aw are of th e risks in volved in using the hard ware in this type of surgery. Moreover, he stated that he was familiar with the FDA regulatory status of the product. Finally, he stated that he did not rely upon certain literature distributed or sponsored by the defen dant in making his de terminations. Thus, the defe ndant’s alleged failure to warn plaintiff is not considered to be the proximate cause of plaintiff’s inju ry under this do ctrine. Wh ile the “indep endent kn owledg e” defen se is 4 not uni versally ac cepted , see Seley v. G.D. Searle & Co., 423 N.E.2d 83 1 Ohio 1981 ), we follow the majority view among th e courts that h ave decid ed this issue, w hich is consiste nt with Tenn essee c ase law . See Ball v. Mallinkrodt Chem. Works, 381 S.W.2d 5 63, 568 (T enn. Ap p. 1964). (T rial Court did not err in refu sing to subm it improper warning claims to jury when “there was no evidence that [the treating physician] relied upon the b rochure an d all of the ev idence sho ws that he was fully aware of the toxicity. . . “). Plaintiff also argues that the Trial Court erred in granting judgment on the issue of his negligence per se claim. The complaint alleges that defendant violated 21 U.S .C. § 36 0 of the Food , Drug and C osmetic Act (“F DCA ”). Plaintiff contends that common law negligence suits are not preempted by the FD CA. See Medtronic, Inc. v. Lohr, 116 S.Ct. 2240 (1996). Although Medtronic establishes that state common law negligence claims are generally not preempted, it does not resolve the precise issue in this case. The defendant does not argue that the negligence per se claim is preempted. Rather, it argues that since the FDCA does not provide for a private right of action, allowing negligence per se claims based on violations of the statute w ould be co ntrary to Cong ressional inten t. 21 U.S.C. §337 provides: Except a s provided in subsectio n (b) of this se ction, all such proc eedings fo r the enforc ement, or to restrain violations, of this chapter shall be by and in the name of the United States. Thus, it is necessary to determine if it would be proper to use the FDCA provision as a basis for a negligence per se claim. In order to recover under the theory of negligence per se, a party must establish three elements. First, the defendant must have violated a statute or ordinance that imp oses a d uty or pro hibition for the b enefit o f a pers on or th e public . Mem phis Street Railway v. Haynes, 81 S.W.374 (Tenn. 1904). Second, the injured party must 5 be within the class of persons intended to benefit from or be protected by the statute. Traylor v. Coburn, 597 S.W.2d 319 (Tenn.App. 1980). Finally, the injured party must show that t he neglig ence was the p roximate caus e of t he in jury. Long v. Brookside Manor, 885 S .W.2d 70 (Te nn. Ap p. 1994 ). The F DCA was d esigne d to pro tect the p ublic as a who le. “Toole v. Richards on-Me rrell, 60 Cal.Rptr. 398, 409 (Cal.Ct.App. 1967) (citing United States v. Sullivan, 332 U.S . 689 (194 8)). Since the statute was designed at least in part to protect the public from unsafe medical products, the plaintiff has met the first two required ele ments. Th e issue thus b ecomes w hether the F DCA ’s lack of a p rivate cause of action precludes using it as a basis for negligence per se claims. We have been cited no Tennessee authority which has determined whether a violation of the FDCA can support a negligence per se claim. Defendant cites Rogers v . Memp his City Sch ools, 1997 W L 6751 94 (Tenn . App.) for its contention that FDCA violations cannot support negligence claims. In Roge rs, the plaintiff sough t to bring a neglig ence a ction un der the T enness ee Tor t Liability A ct. This claim was based in part on the defendant’s alleged violation of the federal Individuals With Disabilities Act (IDEA). The plaintiff sought to recover damages for pain and suffering, which were not available under the remedial provisions of the IDEA. The court determined that the plaintiff could not circumvent or supplement the IDEA’s provisions merely by bringing a state law claim. Since the IDEA constituted “the exclusive remedy for a child with disabilities asserting the right to a free approp riate pub lic educ ation,” th e plaintif f “faile d to state a claim under t he TG TLA .” Id. at *4. While Rogers is an instructive and well-reasoned opinion, it is not precise ly on poin t. First, Rogers obviously dealt with a different statute, with different provisions from the one at issue in this case. Moreover, the IDEA provided an 6 independent remedial scheme whereby injured parties could seek relief. There is no similar provision in the FDCA. Thus, while Rogers provides guidance, it is not dispositive. Other jurisdictions have reached differing results on this issue. Some jurisdictions have allowed plaintiffs to bring negligence claims per se on FDCA violations. In Orthopedic Equip. Co. v. Eutsler, 276 F.2d 455 (4th Cir. 1960), the Fourth C ircuit determin ed that althou gh the FD CA do es not exp ressly provide a civil remedy for in jured cons umers, ma nufacture rs who v iolated their statu tory duties could be sub ject to ne gligenc e per se claims. Accord: Stanton v. Astra Pharmaceutical Prods ., Inc., 718 F.2d 553 (3rd C ir. 1983); Toole v. Richardson-Merrell, Inc., 60 Cal. Rptr. 398 (Cal.Ct.Ap p. 1967). Assuming arguendo that FDCA violations could be the bas is for a negligenc e per se actio n, we belie ve summ ary judgmen t was still appr opriate in this case. The plaintiff alleg es that the de fendant “ marketed , promoted and distribu ted” its product for the purposes which the FDA had not approved, in violation of § 360 of the FDCA . Section 36 0 primarily dea ls with the du ty of produce rs of drugs or devices to register with the Secretary of State for the state in which certain establishm ents are located. It is not clear from plaintiff’s complaint which portion of §360 the defendant is alleged to have violated. Plaintiff may have intended to allege violations of the Medical Device Amendments to the FDCA and not the general reporting require ments o f § 360 . If so, this allegatio n is not s tated in th e com plaint. See T.R.C.P. 8.05 (addressing the pleading of statutory violations). It is not clear how the defendant failed to comply with its statutory duties. The complaint recites several examples of alleged misconduct by defen dant. Assuming th at these instances were breaches of § 36 0, summary judgme nt, nevertheless, was prope r. 7 Assuming defendant did breach § 360, such breach was not the proximate cause of plaintiff’s injuries. Assuming that the Appellant marketed, promoted and distributed its product for non-FDA approved purposes, Dr. Jeffries’ affida vit states t hat he w as fully aw are of th e FDA regulato ry status of this prod uct. The doctor chose to make an “off-label” use of the product. He relied entirely upon his own expertise an d experience in decid ing whether and how to use the d efendant’s product. Accordin g to his affidavit “[m]y profession al decision concerning w hether, how, or where to use instrumentation is not determined by whether a particular use of a particular drug or device has or has not been evaluated by the FDA.” To the extent that the plaintiff’s complaint alleges improper marketing through th e use of ce rtain literature an d promo tional camp aigns, Dr. Je ffries’ affid avit establishes that he was not familiar with, and did not rely upon, any of these marketing techniques. Thus, assuming arguendo, that defendant violated § 360 of the FDCA, such v iolation was n ot, as a m atter of la w, the p roxima te cause of plain tiff’s inju ry. Plaintiff filed a notice of deposition before summary judgment was granted. The Trial Court quashed the notice and granted summary judgment. Plaintiff then filed a motion to alter or amend the final judgment and as a part of that motion, the plaintiff again attached an affidavit stating his need to depose Dr. Jeffries. The Trial Judge also denied this motion. Rule 56.0 7 of the T ennessee Rules of Civil Proce dure prov ides: Should it appear from the affidavits of a party opposing the motion that such party cannot for reasons stated present by affidavit facts essential to justify the opposition, the court may refuse the application for judgmen t or may order a continuan ce to perm it affidavits to be obtained or depositions to be taken or discovery to be had or m ay make suc h other ord er as is just. In this case, the Trial Court did not abuse its discretion in refusing to allow further discovery. Defendant raised the learned intermediary defense in its answer. Over 8 seventeen months p assed bef ore the def endant, relying o n Dr. Jeff ries’ affidav it, moved for summary judgment. The plaintiff waited until the day argument was to be heard on the motion before giving formal notice that he wished to take Dr. Jeffries’ deposition. This was some seventy days after the summary judgment motion had been filed. Und er these circu mstances , we conc lude the T rial Judge d id not abus e his discretio n in den ying this m otion. Finally, plaintiff contends that the Trial Cou rt erred in denying his third proposed amendment to his complaint. Plaintiff moved to amend for a third time on June 30, 1997. Rule 15.01 of the Tennessee Rules of Civil Procedure provides: “A party may amend his pleadings once as a matter of course at any time before a responsive pleading is served . . . [o]therwise a party may amend his pleadings only by written con sent of the a dverse pa rty or by leave of c ourt . . .” Althou gh perm ission to amend should be liberally granted, the decision is “ within the sound discretion of the trial court, and will not be reversed unless abuse of discretion has been shown.” Welch v. Thuan, 882 S.W.2d 7 92, 793 (Tenn.A pp. 1994). Factors the trial court should co nsider wh en decidin g wheth er to allow a mendm ents include “undue d elay in filing; lack of notice to the opposing party; bad faith by the moving party, repeated failure to cure deficiencies by previous amendments, undue prejudice to the opposing party, and futility of amendment.” Merrim an v. Sm ith, 599 S.W.2d 548, 559 (Tenn.App. 19 79). In this case, plaintiff sought to amend his complaint to include allegations th at one of th e nuts hold ing the screw s in his back was loose and that all four of the screws b ecame loo se within h is spine. The report upo n which this amendm ent was b ased is dated Augus t 8, 1995, yet the a ppellant did not attemp t to utilize it before, even when the defendant moved for judgment on the pleadings. The 9 plaintiff attempted to use the operative report as evidence that “[t]he TSRH spinal system and the pedical screws in particular were unreasonably dangerous and defective . . . “ The alleged looseness in the screws, however, was observed only after the product was b eing dismantled, not w hile it was implanted. The screws were observed to be loose o nly after the rod s and con nectors w ere remov ed. There is nothing in th e operative report to estab lish that any of th e screws b ecame loo se while in the pla intiff’s b ack, on ly that one of the n uts wa s loose. For the fo regoing rea sons, we c onclude th e Trial Co urt did not ab use its discretion in d enying this am endmen t. We affirm the judgment of the Trial Court and remand with cost of the appeal asse ssed to the a ppellant. __________________________ Herschel P. Franks, J. CONCUR: ___________________________ Houston M. Godd ard, P.J. ___________________________ Don T. McM urray, J. 1 0